Ebselen has a wide spectrum of interesting therapeutic actions including antioxidant, cytoprotective, neuroprotective and anti-inflammatory activities. Since its antioxidant effect is very well known, this paper links the effects of ebselen in redox cellular status to its possible involvement in the maintenance of the integrity of genomic information by using Saccharomyces cerevisiae strains proficient and deficient in antioxidant defences and the mammalian V79 cell line. Using the alkaline comet assay, we showed that 5-10 mM ebselen does not induce DNA damage in V79 cells. Similarly, these same concentrations diminished the extent of the DNA damage induced by hydrogen peroxide (H 2 O 2 ). The modified comet assay using DNA glycosylases (formamidopyrimidine-DNA glycosylase and endonuclease II) showed that after pre-treatment with ebselen followed by exposure to H 2 O 2 , oxidative damage as recognized by these enzymes was significantly lower. In the same way, ebselen showed strong activity against H 2 O 2 -induced oxidative damage in the anti-mutagenic assay using S.cerevisiae N123 strain and in the antioxidative assay by using S.cerevisiae strains lacking antioxidant defences. This antioxidant effect was more pronounced for the gpx3 D mutant, which indicated that ebselen acts by mimicking the GPx3 catalytic activity. The results confirm that ebselen is involved in antioxidant defence and that its antioxidant ability contributes to its anti-mutagenic and anti-genotoxic action.
Introduction
It has been shown that selenium, an essential trace element for mammals, prevents cancer in many animal model systems and enhances cancer chemopreventive efficacy in humans (1) . In spite of extensive literature describing the anti-mutagenic and anti-carcinogenic effects of selenium compounds, little is known about their mode of action. In addition, selenium compounds have a 'Janus property'-products with a double face-due to their contrasting behaviour, which depends on the concentration used. At low doses, Se exerts beneficial effects, whereas at high doses, it is toxic and possibly carcinogenic. The threshold concentration for these opposing activities has not yet been established (2) .
As the doses of the main known dietary sources of selenium, such as selenomethionine, selenocysteine and inorganic selenium, are limited by toxicity, synthetic derivatives have been developed. In the last few decades, there has been an increasing interest in organoselenium (OS) biochemistry because the pharmacology of synthetic OS compounds revealed molecules that could be used as antioxidants, enzyme inhibitors, neuroprotectors, anti-tumour and anti-infectious agents, cytokine inducers, and immunomodulators (2, 3) .
Ebselen ( Figure 1 ), 2-phenyl-1,2-benzisoselenazol-3(2H)-one, is a cyclic OS, which exhibits interesting therapeutic potential against a number of disease states involving oxidative stress, such as neurological disorders, acute pancreatitis, noiseinduced hearing loss and cardiotoxicity, due to antioxidant, cytoprotective, neuroprotective and anti-inflammatory activities (2, (4) (5) (6) (7) (8) . This molecule is a very well studied OS compound since it is a potent glutathione peroxidase (GPx) mimetic (2, 5, (8) (9) (10) (11) (12) (13) (14) (15) (16) . Interestingly, the beneficial effects of ebselen have been demonstrated in clinical trials for the treatment of patients with delayed neurological deficits after aneurysmal subarachnoid haemorrhage and acute ischaemic stroke (6, 7, (17) (18) (19) (20) .
Since oxidative damage is an important cause of DNA damage and mutation and of carcinogenesis (21) , this study aimed at deepening the existing knowledge on the effects of ebselen on redox cellular status and on the integrity of genomic information. The antioxidant, mutagenic and anti-mutagenic effects of ebselen were investigated in the yeast Saccharomyces cerevisiae strains proficient and deficient in antioxidant defences, while the genotoxicity profile and the anti-genotoxic properties of ebselen were studied in a permanent lung fibroblast cell line derived from Chinese hamsters (V79 cells) using the comet assay.
Materials and methods

Chemicals
Ebselen (Chemical Abstracts Series registry number 60940-34-3), 4-nitroquinoline oxide, sodium azide, amino acids (L-histidine, L-threonine, Lmethionine, L-tryptophan, L-leucine, L-lysine), L-canavanine, nitrogen bases (adenine and uracil) and dimethyl sulfoxide (DMSO) were purchased from Sigma (St Louis, MO, USA). Dulbecco's modified Eagle medium (DMEM), foetal bovine serum (FBS), trypsin-ethylenediaminetetraacetic acid (EDTA), Lglutamine and antibiotics were purchased from Gibco BRL (Grand Island, NY, USA). Agarose and low-melting point agarose were obtained from Invitrogen (Carlsbad, CA, USA). Hydrogen peroxide (H 2 O 2 ) at 30% was purchased from Aldrich (Milwaukee, WI, USA). Yeast extract, bacto-peptone and bacto-agar were obtained from Difco Laboratories (Detroit, MI, USA). Formamidopyrimidine-DNA glycosylase (FPG) and endonuclease III (EndoIII) were obtained from New England BioLabs (Beverly, MA, USA). All other reagents were of analytical grade. The tissue culture flasks (bottles and dishes) were supplied by Nunc (Wiesbaden, Germany).
Yeast strains and media
The relevant genotypes of S.cerevisiae strains used in this work are given in Table I . Haploid strains XV185-14c and N123 were used in the mutagenicity assay. The yeast strains defective in antioxidant defence, Yap1 transcription factor, superoxide dismutase and GPx3, as well as their isogenic wild-type *To whom correspondence should be addressed. Tel: þ55 51 34774000; Fax: þ55 51 34779214; E-mail: jenifer.saffi@ulbra.br Ó The Author 2008. Published by Oxford University Press on behalf of the UK Environmental Mutagen Society. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org. strain, were used in the evaluation of antioxidant potential in yeast. Media, solutions and buffers were prepared according to Burke et al. (22) . Complete YPD medium, containing 0.5% yeast extract, 2% bacto-peptone and 2% glucose was used for routine growth of yeast cells. For plates, the medium was solidified with 2% bacto-agar. The minimal medium (MM) contained 0.67% yeast nitrogen base without amino acids, 2% glucose and 2% bacto-agar supplemented with the appropriate amino acids. Synthetic complete (SC) medium was MM supplemented with 2 mg adenine, 2 mg arginine, 5 mg lysine, 1 mg histidine, 2 mg leucine, 2 mg methionine, 2 mg uracil, 2 mg tryptophan and 24 mg threonine per 100 ml of MM. For XV-185-14c strain mutagenesis, the omission media lacking lysine (SC-lys), histidine (SC-his) or homoserine (SChom) were used. Synthetic medium without arginine, supplemented with 60 lg/ ml canavanine, was used for the detection of forward mutation in N123 strain.
For cell treatment, ebselen stock solutions were prepared immediately prior to use by dissolution in DMSO. The subsequent dilutions were carried out in distilled water and DMSO concentration in the incubation mixture never exceeded 0.2%. All treatments were carried out in the dark.
Yeast growth
Stationary phase cultures were obtained by inoculation of an isolated colony into liquid YPD medium. After 48 hours incubation at 30°C with aeration by shaking, the cultures contained 1-2 Â 10 8 cells/ml. Cells were harvested and washed twice with saline solution (NaCl 0.9%). Cell concentration and percentage of budding cells in each culture were determined in a Neubauer chamber by microscope counts.
Growth inhibition assay in yeast cells
An inoculation loop of cells from a stationary phase cell suspension was streaked from the center to the rim of a Petri dish with complete medium in one continuous stroke. A filter paper disk was placed in the center of the dish and increasing ebselen concentrations (10, 25, 50 and 100 lM) were applied onto the disk. Dishes were pre-incubated for 4 hours at 30°C. Afterwards, 5 ll 30% H 2 O 2 was placed on a same filter paper disk and incubated for 2 days at 30°C. Impaired growth was measured as centimetre of growth inhibition from the border of the filter disk to the beginning of cell growth. Values ranged from 0 (complete growth to the filter disk) to 3 cm (absence of growth to the rim of the Petri dish).
Detection of ebselen-induced reverse and frameshift mutation in S.cerevisiae The strain XV185-14c was used for this evaluation. A suspension of 2 Â 10 8 cells/ml in stationary phase was incubated for 2 hours at 30°C with different ebselen concentrations in phosphate-buffered saline (PBS) solution, pH 7.4. After treatment, appropriate cell dilutions were plated onto SC medium to determine cell survival (3-5 days, 30°C) and in the appropriate omission media (7-10 days, 30°C) to evaluate mutation induction (LYS, HIS or HOM revertants). Whereas his1-7 is a non-suppressible missense allele and reversions result from mutation at the locus itself (23), lys1-1 is a suppressible ochre nonsense mutant allele (24) which can be reverted either by locus-specific or forward mutation in a suppressor gene (25) . True reversions and forward (suppressor) mutations at the lys1-1 locus were differentiated according to Schuller and von Borstel (26) , where the reduced adenine content of the SC-lys medium shows locus reversions as red and suppressor mutations as white colonies. The hom3-10 mutant allele of haploid strain XV185-14c was used for assaying putative frameshift mutagenesis. It is believed that hom3-10 contains a frameshift mutation due to its response to a range of diagnostic mutagens (25) . Assays were repeated at least four times and plating was performed in triplicate for each dose.
Detection of ebselen-induced forward mutation in S.cerevisiae N123 strain was used for the evaluation of mutagenicity as well as of the protective effect of the ebselen against H 2 O 2 -induced mutagenesis since this strain is very responsive to H 2 O 2 because it shows low glutathione content (27) . Forward mutation was measured with the canavanine resistance assay (CAN1 / can1). Wild-type yeast strains express the arginine transporter which also imports canavanine, toxic akin, lead up to cell death. Alterations in the CAN1 gene that impair Can1p functionality can increase cellular survival in the presence of canavanine. Cell suspensions in stationary growth phase (2 Â 10 8 cells/ml) were incubated in PBS, for 1 hour at 30°C with different ebselen concentrations. After treatment, appropriate cell dilutions were plated onto SC plates to determine cell survival, and 100 ll aliquots of cell suspensions (2 Â 10 8 cells/ml) were plated onto SC media supplemented with 60 lg/ml canavanine in order to determine forward mutation in CAN1 locus. Mutants were counted after 4-5 day incubation at 30°C.
For anti-mutagenesis evaluation, the cells were submitted to pre-treatment with non-cytotoxic ebselen concentration for 2 hours with shaking at 30°C. Cells were harvested, washed and H 2 O 2 was added to a 4-mM final concentration. The mixture was further incubated at 30°C for another hour. After treatment, appropriate cell dilutions were plated onto SC plates to determine cell survival and were plated onto SC media supplemented with 60 lg/ml canavanine to determine forward mutagenesis. Plates were incubated in the dark at 30°C for 3-5 days before counting surviving and mutant colonies. Assays were repeated at least three times and plating was in triplicate for each dose.
V79 Cell culture and treatments V79 cells (Chinese hamster lung fibroblasts) were grown as monolayers under standard conditions in DMEM supplemented with 10% heat-inactivated FBS, 0.2 mg/ml L-glutamine, 100 IU/ml penicillin and 100 lg/ml streptomycin. Cells were maintained in tissue culture flasks at 37°C in a humidified atmosphere containing 5% CO 2 and were harvested by treatment with 0.15% trypsin-0.08% EDTA in PBS. Cells were seeded (3 Â 10 6 cells) in 5 ml of complete medium in a 25-cm 2 flask and grown for 2 days to 70% confluence prior to the treatment with the test substance.
Cells were treated with ebselen (0, 5, 10 and 50 lM) in FBS-free medium for 2 hours at 37°C in a humidified atmosphere containing 5% CO 2 . To evaluate the anti-genotoxic potential of this OS molecule, cells were then washed with PBS at and submitted to the mutagen experimental protocol. To perform oxidative challenge, cells were exposed to 150 lM H 2 O 2 for 1 hour under the same conditions. The culture flasks were protected from direct light during treatment with ebselen and H 2 O 2 . Genotoxic evaluation using comet assay in V79 cells The alkaline comet assay was performed as described by Singh (28) with minor modifications (29, 30) . After treatment, cells were washed with ice-cold PBS, trypsinized and re-suspended in complete medium. Then, 20 ll cell suspension (3 Â 10 6 cells/ml) was mixed with 0.75% low-melting point agarose and immediately spread onto a glass microscope slide pre-coated with a layer of 1% normal melting point agarose. Agarose was allowed to set at 4°C for 5 min. Slides were incubated in ice-cold lysis solution (2.5 M NaCl, 10 mM Tris, 100 mM EDTA, 1% Triton X-100 and 10% DMSO, pH 10.0) at 4°C for at least 1 hour to remove cell proteins, leaving DNA as 'nucleoids'. In the modified comet assay, the slides were removed from the lysing solution and washed three times in enzyme buffer (40 mM N-2-hydroxyethylpiperazine-N#-2-ethanesulfonic acid, 100 mM KCl, 0.5 mM EDTA, 0.2 mg/ml bovine serum albumin, pH 8.0), drained and incubated at 37°C in this buffer with 60 ll of FPG [for detection of oxidized purines, mainly 8-oxo-7,8-dihydro-2#-deoxyguanosine (8-oxodG); 1 lg/ml solution; 100 mU per gel] for 30 min and EndoIII (for detection of oxidized pyrimidines; 1 lg/ml solution; 100 mU per gel) for 45 min. After lysis, slides were placed on a horizontal electrophoresis unit, covered fresh buffer (300 mM NaOH, 1 mM EDTA, pH 13.0) for 20 min at 4°C to allow DNA unwinding and the expression of alkalilabile sites. Electrophoresis was performed for 20 min at 25 V and 300 mA (0.90 V/cm). All the steps above were conducted under yellow light or in the dark in order to prevent additional DNA damage. Slides were then neutralized (0.4 M Tris, pH 7.5), washed in bi-distilled water and stained using a silver nitrate staining protocol as described by Nadin et al. (31) . After drying at room temperature, gels were analysed using an optical microscope. One hundred cells (50 cells from each of the two replicate slides) were selected and analysed for the concentration of each test substance. When selecting cells, the edges and cells around air bubbles were avoided (32) . Cells were visually scored according to tail length into five classes: (i) class 0: undamaged, without a tail; (ii) class 1: with a tail shorter than the diameter of the head (nucleus); (iii) class 2: with a tail length 1-2Â the diameter of the head; (iv) class 3: with a tail longer than 2Â the diameter of the head and (v) class 4: comets with no heads. A value [damage index (DI)] was assigned to each comet according to its class. For the visual score analysis, the slides were coded and scored blind.
International guidelines and recommendations for the comet assay consider that visual scoring of comets is a well-validated evaluation method (33) . The DI is based on the length of migration and on the amount of DNA in the tail, and it is considered a sensitive DNA measurement. DI and damage frequency were emphasized in our analyses. The other parameters, as image length, were only used as complementary DNA damage parameters. DI ranged from 0 (completely undamaged: 100 cells Â 0) to 400 (with maximum damage: 100 cells Â 4) (29, 30, 32, 34) . Damage frequency (%) was calculated based on the number of cells with tails versus those without tails. The vehicle was used as negative control.
Statistical analysis
Data are presented as means AE standard deviation (34) and analysed using oneway analysis of variance with Dunnett's multiple comparison test. Differences between the control group and different doses of the ebselen were considered significant when P , 0.05.
Results
Antioxidative assay in S.cerevisiae The treatment with ebselen protects against H 2 O 2 cytotoxicity in yeast lacking antioxidant defences and in wild-type strains, as shown in Figure 2 . None of the applied ebselen concentrations alone had any significant cytotoxic effect on the yeast strains tested (survival of colony forming ability 90-95%, data not shown). Similarly, the ebselen concentrations did not inhibit growth. As expected, H 2 O 2 had an important toxic effect in yeast, verified by the increased inhibition of growth ratio. The treatment of different mutant strains (sod1D, sod2D, sod1Dsod2D, gpx3D, yap1D and wild type) with this OS compound markedly decreased the response to the toxic effect of the H 2 O 2 . This increase in the survival score does occur in a dose-related manner, and is identical for all strains used, independently of the type of lacking enzymatic defence. In this manner, at this concentration range, ebselen acts as an antioxidant in yeast.
Mutagenic and anti-mutagenic effects in S.cerevisiae Results of mutagenicity tests are shown in Tables II and III. Ebselen was neither cytotoxic nor mutagenic, at the concentration range employed in yeast, since the survival rate did not decrease. Moreover, it did not significantly increase the revertants ratio at the his1, lys1 and hom3 loci in the strain XV185-14c (Table II) . In the same way, in N123 strain, ebselen treatment did not induce forward mutation (Table III) .
In this manner, we have chosen this concentration range to follow experiments to verify the protective effects of ebselen on the H 2 O 2 -induced forward mutation in N123 yeast strain. Table IV shows that ebselen treatment increases the survival of strain N123 during H 2 O 2 treatment and simultaneously reduces, in a dose-dependent manner, the H 2 O 2 -induced forward mutagenesis. In this manner, our findings clearly show that ebselen exerts an anti-mutagenic effect against oxidative mutagenesis in yeast. 
Effects in V79 cells
In order to evaluate the ebselen genotoxicity, we investigated whether this compound could induce DNA damage under these experimental conditions. The in vitro alkaline (pH .13) comet test is the most frequently used assay for routine screening of potential genotoxic agents (30) and can be performed with a variety of cell types, including V79 cell lines. The alkaline version of the comet assay detects primary (repairable) DNA single-and double-strand breaks, alkali-labile sites cross-links and incomplete excision repair sites (30) .
Ebselen did not generate significant DNA damage at concentrations ,50 lM (Table IV) . However, it induced DNA damage at 50 lM (Table IV) . We also investigated the antioxidant effect of this OS molecule against H 2 O 2 -induced DNA damage at concentrations from 5 to 50 lM. At 5 lM concentration, the treatment with this compound reduced the H 2 O 2 -induced DNA damage. At 10 and 50 lM, the protective effect is not observed and DI is increased, suggesting that at these concentrations it contributes to genotoxic effects.
In order to determine the nature of the antioxidant effect on V79 cells exerted by this interesting molecule, we carried out the modified comet assay. Table V presents the mean DNA damage of ebselen as DI after treatment with DNA repair enzymes EndoIII and FPG. Therefore, the results indicate that at 5 and 10 lM ebselen did not induce significant oxidative damage, as expected (Table V) . H 2 O 2 treatment increases the extent of oxidative DNA damage recognized by EndoIII and FPG in V79 cells, indicating the presence of oxidized pyrimidines and oxidized purines, respectively. When the cells were pre-treated with ebselen and then exposed to H 2 O 2 , the extension of oxidative damage recognized by these enzymes decreases significantly, indicating that at these concentrations ebselen has an anti-genotoxic effect on V79 cells due to its antioxidant effect (Figure 3 ). This effect was more pronounced in reduced FPG-sensitive sites induced by H 2 O 2 . This suggests that ebselen reveals the strongest inhibition of FPG-sensitive sites or EndoII-sensitive sites preventing oxidative damage in both treatments with these enzymes.
Discussion
Ebselen-the most studied synthetic OS compound-has antioxidant properties that have attracted a great deal of attention since its discovery in 1984. In this study, we used Table II . Induction of point mutation (his1-7), ochre allele (lys1-1) and frameshift (hom3-10) mutations in haploid XV185-14c strain of Saccharomyces cerevisiae, after ebselen treatment for 2 hours in non-growth conditions and stationary phase S.cerevisiae to explore the antioxidant and anti-mutagenic effects of this molecule against oxidative mutagenesis since yeast seems to be a potentially useful eukaryotic model for studies on the molecular mechanisms underlying the effects of pharmacodynamic molecules (35) . Moreover, we evaluated the genotoxic profile of this OS in V79 fibroblasts, well characterized and commonly used in mutagenicity and cytotoxicity studies, as well as the protective effect of ebselen against DNA damage induced by oxidative challenge (36) . H 2 O 2 was chosen for oxidative challenge in yeast and V79 cells because it is genotoxic and capable of inducing oxidative DNA damage, including DNA strand breakage and base modification (21) . The yeast S.cerevisiae has been a useful model for studies of the eukaryotic response to oxidant challenge and for investigating the interplay between stress resistance and levels of damaged cell components, such as DNA. Although mutations are often induced at higher frequency in exponential as compared to stationary phase, in this work, we have used cells in stationary phase since these resemble cells of multicellular organisms in various aspects; for example, most energy comes from mitochondrial respiration, cells are in the G 0 phase and, especially, damage accumulates over time. In stationary phase cells, damage cannot be diluted since cell division and new synthesis are not occurring (35) .
Ebselen, at the concentration range employed, was neither cytotoxic nor mutagenic in yeast strains (Table III and  Table IV ), and the treatment was able to prevent oxidative mutagenesis induced by H 2 O 2 (Table IV) . In order to evaluate the role of the antioxidant effect of this OS molecule in its anti-mutagenic potential, a determination of the protection of ebselen against H 2 O 2 cytotoxicity was performed using the growth inhibition assay in wild-type and isogenic strains lacking antioxidant defences. The results showed that after the treatment with ebselen, a decrease in the growth inhibition induced by the H 2 O 2 took place, indicating the possibility of antioxidant protection (Figure 2 ). This antioxidant effect was more pronounced for the gpx3D mutant, which indicated that ebselen acts as scavenger by mimicking the catalytic activity of GPx3, as expected. It is also important to note the antioxidant response observed in the yap1 mutant, which is very sensitive to oxidative stress since Yap1 is a key regulator of oxidative stress tolerance in S.cerevisiae (37) . Our results thus demonstrate a putative direct action of ebselen as reactive oxygen species (ROS) scavenger, probably by GPx-like action, rather than an induction of other antioxidant defences that would lead to an adaptive response in yeast.
Reinforcing the results obtained in yeast, the treatment with this OS molecule at low concentrations was not genotoxic to V79 cells. Moreover, it protects against H 2 O 2 -induced oxidative damage as verified by the decrease in the DI in the standard comet assay (Table III) . The role of antioxidant action of ebselen in the anti-genotoxic effect on V79 cells was assessed using the modified comet assay. The standard alkaline method gives limited information on the type of DNA damage being measured as it is not possible to determine whether it is a consequence of direct effects of the damaging agent, or of indirect effects, such as oxidative damage. The sensitivity and specificity of the assay can be improved by incubating the lysed cells (nucleoids) with lesion-specific endonucleases, which recognize particular damaged bases and create additional breaks. In this work, we have used FPG, which is specific for oxidized purines, including 8-oxo-7,8-dihydroguanine, 2,6-diamino-4-hydroxy-5-formamidopyrimidine and 4,6-diamino-5-formamidopyrimidine and other ring-opened purines, and also EndoIII, which recognizes oxidized pyrimidines, including thymine glycol and uracil glycol (38) . As shown in Table V , ebselen reduces, more effectively, the FPG-sensitive sites by inhibiting the formation the oxidized purines.
The exposure of living cells to various oxidizing agents such as peroxides, singlet oxygen and ultraviolet and ionizing irradiation leads to hydroxylation of DNA constituents such as 2#-deoxyguanosine, which gives rise to 8-hydroxydeoxyguanosine and its tautomer 8-oxodG at physiological pH (7, (39) (40) (41) . According to our findings, ebselen was able to decrease 8-oxodG levels in in vitro studies using rat liver DNA treated with peroxides (42) . In addition, in a model of ischemic damage in rat brain, ebselen-treated animals had a reduction in cellular damage and a clear decrease in the levels of hydroxylated 2#-deoxyguanosine products (7) . In rat liver, this OS molecule significantly inhibited the increase in the level of 8-oxodG generated by aflatoxin B1 treatment, which may contribute to its protective effect against the carcinogenicity of aflatoxin B1 (42) .
The present study presents evidence that ebselen has a strong protective effect against H 2 O 2 -induced oxidative DNA damage in yeast and V79 cells. The reason for this protection probably resides in an additional antioxidant protection, mainly in virtue of its GPx-mimetic action. In this respect, ebselen has antioxidative properties as it can act as a Gpx mimic in reducing H 2 O 2 and lipid hydroperoxides. Also, ebselen scavenges the highly reactive species peroxynitrite and inactivates free radical-generating enzymes such as lipoxygenase, cyclooxygenase and reduced nicotinamide adenine dinucleotide phosphate oxidase (43) .
In in vitro models, ebselen protects against oxidative DNA damage induced by dopamine in the presence of copper ions (19) . Similarly, it provides potent protection against ROSinduced cytotoxicity and DNA damage in HepG2 and HL-60 cell lines, through its antioxidant properties (44, 45) . Ebselen also protects against aflatoxin B1 cytotoxicity via its strong ability to scavenge intracellular ROS and to prevent oxidative damage (46) . Furthermore, it can inhibit pre-neoplasic changes caused by aflatoxin B1, at least in part, due the protective effect against oxidative damage (42) . In this sense, some previous studies confirm that OS compounds, as selenomethionine and selenocysteine, are neither toxic nor mutagenic in similar doses in yeast and have a protective effect against H 2 O 2 -induced mutagenesis by means of reinforcing antioxidant cell potential (47) .
Similarly to other OS compounds, ebselen presents antigenotoxic effect in V79 cell activity at low doses, in the range upon 5 lM. In agreement with literature data, this molecule reduces ROS formation and the DNA-damaging effect caused by H 2 O 2 in HepG2 cells at 1-25 lM (44). Also, ebselen protects ECV-304 cells against oxysterols at 2 lM (48). The neuroprotective actions of ebselen are at 0.01-20 lM, with the best results obtained at 8 lM (49) . In this manner, our results in V79 cells are consistent with those reported in the literature, which show that some OS compounds exhibit protective potential at lower concentrations.
However, ebselen is genotoxic to V79 cells in concentrations of up to 10 lM, as verified in the alkaline comet assay (Table  IV) . Indeed, it depletes glutathione in HepG2 cells in this concentration range, inducing apoptosis through rapid depletion of intracellular thiols (50) . In view of this, ebselen has an interesting anti-proliferative potential in tumoural cells lines, as observed in the growth inhibition of MCF-7 cells and in the cell death induction in Sp2/O-Ag14 hybridoma cells and in the C6 glioma cell line (51) (52) (53) . In addition, a recent in vivo study showed that ebselen presented a pro-oxidative effect on the livers of suckling rat pups (54) . Our findings reinforce these cytotoxic effects above the threshold concentration and suggest the possibility that the DNA damage induced by ebselen can be involved, at least in part, in its anti-proliferative effect. Furthermore, DNA-damaging capacity is useful to trigger signalling pathways that lead to apoptosis, and this has been considered a promising characteristic in the search for new OS derivative compounds with anti-tumoural effect (55) .
In summary, the present findings suggest that ebselen is capable of protecting against H 2 O 2 -induced cytotoxicity and DNA damage and mutation in the yeast S.cerevisiae as well as in V79 cultured cells. It is neither cytotoxic nor induces mutagenicity in yeast S.cerevisiae, and it is able to protect against growth inhibition induced by H 2 O 2 in yeast strains defective in antioxidant defence. In V79 cells, ebselen is not genotoxic at concentrations of up to 10 lM, and it protects against oxidative DNA damage by its antioxidant activity, as observed in the modified comet assay. However, at concentrations above 10 lM in V79 cells, this molecule is genotoxic and induces DNA damage. Besides all these interesting properties, more studies concerning clinical trials are still necessary for its safe therapeutic application and for the development of more potent derivatives or those that present other pharmacological effects.
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